The regulatory maze behind health tech vaporware

  • 📰 verge
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 67%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

FDA clearance is necessary but complicated.

“It is no small task to be a medical device company, build this infrastructure, build all the standard operating procedures that the FDA wants to see,” says Movano Health CEO John Mastrototaro, whose company is working on making an FDA-cleared smart ring for consumers.

When I caught up with Mastrototaro at this year’s CES, he wasn’t fazed much. Instead, he pointed to the fact that the ring — now called Evie, short for “evidence”— successfully passed a hypoxia trial in October 2022, showing clinical-level accuracy for heart rate and oxygen saturation measurements. The FDA, Mastrototaro says, requires accuracy across a broad range of oxygen levels with a margin of error of 4 percent. That has to be tested for women, men, and people of all skin tones.

But if successful, the Evie Ring would be one of the first consumer wearables fully cleared as a medical device.FDA clearance may also be the only way a company can get novel health tech into the hands of consumers. For the past, Valencell — a wearable tech provider to companies like LG, Jabra, and Bose — has been at CES showcasing its noninvasive blood pressure monitoring tech using photoplethysmography sensors.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 94. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA paused trials for experimental drugs more often in recent yearsThe Food and Drug Administration has increasingly exercised its power to delay drug companies' testing of experimental drugs in recent years, a possible byproduct of newer medical technologies that offer promise but may pose additional risks. neiltyson patrickbetdavid
Source: dcexaminer - 🏆 6. / 94 Read more »

A new FDA-approved Alzheimer's medicine slowed cognitive decline in patientsThe ​US FDA approved Leqembi, a new drug that is intended to slow down cognitive decline in patients who have mild or early-stage Alzheimer's disease. I thought I saw a report it also shrunk the brain.
Source: IntEngineering - 🏆 287. / 63 Read more »